Top 10 Companies in the China 2‑Methyl‑5‑Bromopyridine Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

The China 2‑Methyl‑5‑Bromopyridine market size was valued at USD 13.6 million in 2024. The market is projected to grow from USD 14.3 million in 2025 to USD 19.8 million by 2032, exhibiting a CAGR of 5.2% during the forecast period.

2‑Methyl‑5‑Bromopyridine is a brominated pyridine derivative primarily used as a key intermediate in pharmaceutical synthesis and agrochemical production. This heterocyclic compound serves as a versatile building block for constructing complex molecules, particularly in medicinal chemistry applications where modified pyridine structures are essential. The chemical’s reactive bromine substituent enables diverse functionalization, making it valuable for synthesizing active pharmaceutical ingredients (APIs) and crop protection agents.

The market growth is driven by China’s expanding pharmaceutical sector, which accounted for 68% of total consumption in 2024. Rising demand for high‑purity (≥99%) grades, particularly for electronic applications, grew 7% year‑over‑year in 2024. Domestic production reached 680 metric tons last year, with capacity expansions underway at major manufacturers to meet projected demand increases of 4‑6% annually through 2032.

China 2‑Methyl‑5‑Bromopyridine Market – View in Detailed Research Report

---

Top 10 Companies in the China 2‑Methyl‑5‑Bromopyridine Market

Below are the market leaders driving innovation, capacity expansion, and sustainability in the 2‑Methyl‑5‑Bromopyridine segment.

1️⃣ Anhui Bayi Chemical Industry Co. Ltd.

Headquarters: Anhui, China
Key Offering: High‑purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates and agrochemicals

Anhui Bayi has secured a 22% market share in 2024 by leveraging its vertically integrated production and extensive distribution network across China’s pharmaceutical hubs. The company’s continuous‑flow bromination units have improved yields by 15% while reducing hazardous waste.

Sustainability Initiatives:

• Implementation of closed‑loop solvent recovery systems, cutting solvent use by 35%
• Adoption of greener bromination catalysts with lower environmental impact
• Partnerships with local universities for R&D on sustainable synthesis

2️⃣ Shanghai Synica Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Advanced chemical intermediates for cardiovascular and neurological drug development

Shanghai Synica accounts for nearly 15% of the market, focusing on high‑purity intermediates required for complex API synthesis. The company has invested heavily in continuous‑flow chemistry, achieving a 12% increase in production efficiency.

Sustainability Initiatives:

• Integrated waste‑to‑energy conversion for by‑products
• Emission reduction targets aligned with national environmental regulations
• Collaborations with global pharma firms to develop greener production routes

3️⃣ Jiangsu Hualun Chemical Industry Co., Ltd.

Headquarters: Jiangsu, China
Key Offering: Cost‑effective 2‑Methyl‑5‑Bromopyridine for agrochemical applications

With a combined market share of 12%, Jiangsu Hualun specializes in large‑scale production, supplying agrochemical manufacturers across China and exporting to Southeast Asia.

Sustainability Initiatives:

• Implementation of catalytic bromination processes that increase atom economy by 20%
• Participation in national green chemistry pilot projects
• Energy‑efficient plant upgrades to reduce carbon footprint

4️⃣ Hangzhou Dayangchem Co. Ltd.

Headquarters: Hangzhou, China
Key Offering: High‑purity intermediates for pharmaceutical and electronic‑grade applications

Dayangchem’s focus on electronic‑grade purity (≥99.9%) positions it as a preferred supplier for the burgeoning organic electronics industry.

Sustainability Initiatives:

• Zero‑liquid‑discharge (ZLD) system for by‑product management
• Investment in renewable energy sources for plant operations
• Research into bio‑based bromination reagents

5️⃣ Nanjing Chemlin Chemical Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Specialty intermediates for advanced pharmaceutical synthesis

Chemlin serves niche pharmaceutical clients, delivering custom‑grade 2‑Methyl‑5‑Bromopyridine with stringent purity specifications.

Sustainability Initiatives:

• Process optimization to reduce solvent usage by 28%
• Collaboration with pharma R&D centers on green chemistry
• Certification under ISO 14001 environmental management

6️⃣ Hubei Jusheng Technology Co., Ltd.

Headquarters: Hubei, China
Key Offering: Continuous‑flow bromination technology and intermediates

Jusheng focuses on technology transfer, providing turnkey continuous‑flow solutions to other manufacturers while producing high‑purity intermediates.

Sustainability Initiatives:

• Adoption of recyclable catalyst systems
• Integration of real‑time process monitoring for waste minimization
• Participation in national “Clean Production” programs

7️⃣ Shandong Chuangying Chemical Co., Ltd.

Headquarters: Shandong, China
Key Offering: Bulk production of 2‑Methyl‑5‑Bromopyridine for agrochemical manufacturers

Chuangying’s large‑scale operations support China’s agrochemical sector, providing cost‑effective intermediates for pesticide synthesis.

Sustainability Initiatives:

• Implementation of low‑energy continuous‑flow units
• Waste‑to‑energy conversion for excess by‑products
• Compliance with national emission standards

8️⃣ Wuhan Fortuna Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Specialty intermediates for pharmaceutical and agrochemical sectors

Fortuna’s focus on high‑purity grades and rapid delivery makes it a preferred supplier for domestic pharmaceutical companies.

Sustainability Initiatives:

• Adoption of green solvent systems
• Energy‑efficient plant design with renewable energy integration
• Continuous improvement of process safety standards

9️⃣ Zhejiang Kaili Industrial Co., Ltd.

Headquarters: Zhejiang, China
Key Offering: Advanced intermediates for pharmaceutical and electronic applications

Kaili Industrial supplies high‑purity intermediates to both domestic and international clients, emphasizing strict quality control.

Sustainability Initiatives:

• Implementation of zero‑waste manufacturing protocols
• Investment in renewable energy for plant operations
• Collaboration with global R&D centers on sustainable synthesis

🔟 Changzhou Extraordinary Pharmatech Co., Ltd.

Headquarters: Changzhou, China
Key Offering: Continuous‑flow synthesis of high‑purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates

Changzhou Extraordinary Pharmatech has achieved a 18% increase in production efficiency through its proprietary continuous‑flow technology, capturing market share in the premium segment.

Sustainability Initiatives:

• Use of catalytic bromination with reduced hazardous waste
• Closed‑loop solvent recovery system
• Partnerships with academic institutions for green chemistry research

---

Download FREE Sample Report:
China 2‑Methyl‑5‑Bromopyridine Market – View in Detailed Research Report

Get Full Report:
China 2‑Methyl‑5‑Bromopyridine Market – View in Detailed Research Report

---

Outlook: The Future of China 2‑Methyl‑5‑Bromopyridine Market

China’s 2‑Methyl‑5‑Bromopyridine market is poised for steady expansion, driven by robust demand from pharmaceutical and agrochemical sectors. The market is expected to grow from USD 13.6M in 2025 to USD 19.8M by 2034, reflecting a sustained CAGR of 5.2%.

Key Trends Shaping the Market

• Continued growth of China’s pharmaceutical industry, with a projected market size exceeding USD 300B by 2025.
• Increasing demand for high‑purity (≥99%) intermediates in electronic‑grade applications, growing at 7% YoY.
• Adoption of continuous‑flow chemistry, improving yields by 12% and reducing environmental impact.
• Expansion of agrochemical production, with demand for advanced pesticides rising at 5% annually.
• Regulatory focus on sustainability, driving green chemistry innovations and higher price premiums for eco‑friendly intermediates.

---

Future Trends: Emerging Technologies and Market Dynamics

The next decade will see significant shifts in production technology, supply chain resilience, and application diversification.

• Advances in catalytic bromination and solvent recovery will reduce hazardous waste by up to 40%.
• Growth of organic electronics will triple demand for electronic‑grade intermediates by 2030.
• Digitalization of supply chains will enhance traceability and quality control.
• Strategic partnerships between intermediate manufacturers and API producers will secure long‑term offtake agreements.
• Geopolitical dynamics and trade policy shifts will continue to influence export volumes and pricing.